Utah Medical Products Q3 2025 earnings released; financial data not available in excerpt

UTAH MEDICAL PRODUCTS INC

2025-Q3 EPS reported $2.68 revenue$29,475,000

Q3 and nine-month period ended September 30, 2025 results reported via press release.
Specific revenue, EPS, and segment figures are not present in the provided text.
Forward-looking statements for 2025 and beyond accompany the release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.